Cadila’s biosimilar at 20% of Humira price

You heard it right, the new biosimilar of adalimumab (brand name: Humira by Abbvie) was launched by Zydus Cadila with the name of Exemptia in India. This is the first biosimilar of adalimumab which is currently priced at one-fifth of Humira’s. (Read full article here) Biosimilars are significant biopharmaceutical products in  many countries in Asia. These biological products are similar, or  highly …